Noninvasive hippocampal blood−brain barrier opening in Alzheimer’s disease with focused ultrasound

The blood–brain barrier (BBB) presents a significant challenge for treating brain disorders. The hippocampus is a key target for novel therapeutics, playing an important role in Alzheimer’s disease (AD), epilepsy, and depression. Preclinical studies have shown that magnetic resonance (MR)-guided low...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezai, Ali R., Ranjan, Manish, D’Haese, Pierre-François, Haut, Marc W., Carpenter, Jeffrey, Najib, Umer, Mehta, Rashi I., Chazen, J. Levi, Zibly, Zion, Yates, Jennifer R., Hodder, Sally L., Kaplitt, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2020
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196825/
https://www.ncbi.nlm.nih.gov/pubmed/32284421
http://dx.doi.org/10.1073/pnas.2002571117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196825/
https://www.ncbi.nlm.nih.gov/pubmed/32284421
http://dx.doi.org/10.1073/pnas.2002571117

Ejemplares similares